Compare JANX & SID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JANX | SID |
|---|---|---|
| Founded | 2017 | 1941 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 833.8M |
| IPO Year | 2021 | 2002 |
| Metric | JANX | SID |
|---|---|---|
| Price | $10.13 | $0.51 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 18 | 4 |
| Target Price | ★ $33.14 | $1.17 |
| AVG Volume (30 Days) | 946.4K | ★ 10.8M |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,000,000.00 | N/A |
| Revenue This Year | $174.21 | N/A |
| Revenue Next Year | N/A | $1.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.16 | $0.55 |
| 52 Week High | $35.34 | $2.20 |
| Indicator | JANX | SID |
|---|---|---|
| Relative Strength Index (RSI) | 25.34 | 24.87 |
| Support Level | N/A | N/A |
| Resistance Level | $14.47 | $1.34 |
| Average True Range (ATR) | 1.16 | 0.07 |
| MACD | -0.48 | -0.02 |
| Stochastic Oscillator | 0.33 | 1.23 |
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations port concessions and fleets of road transport vehicles. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.